Cut The Clutter: What’s monoclonal antibody Donald Trump took, how it works & two happy blows on behalf of science

On 2 October, the White House announced President Donald Trump received an experimental monoclonal antibody treatment from the pharma firm Regeneron. In episode Shekhar Gupta explains the science of this therapy works, its promise and challenges. He also celebrates two blows struck on behalf of modern science.